Skip to content

Robot-assisted oblique lateral approach lesion debridement combined with percutaneous pedicle screw internal fixation in a single lateral position in the treatment of lumbar tuberculosis

Robot-assisted oblique lateral approach lesion debridement combined with percutaneous pedicle screw internal fixation in a single lateral position in the treatment of lumbar tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115723
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar tuberculosis

Interventions

Traditional posterior surgery group:Traditional posterior approach surgery
Robot-assisted OLIF+PPSF group:Robot-assisted OLIF+PPSF

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed preoperatively with single-segment lumbar tuberculosis (L1/2-L5/S1) and proposed for surgical treatment; 2. This admission is for the first spinal surgery; 3. Age 18-70 years; 4. American Society of Anesthesiologists (ASA) classification: I; 5. Body Mass Index (BMI, kg/m^2) between 18 and 30; 6. Preoperative lumbar MRI indicates a suitable OLIF surgical window between the psoas major muscle and large blood vessels; 7. Voluntarily agrees to participate in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Preoperative/postoperative genetic testing or pathological examination suggests drug-resistant tuberculosis or non-tuberculosis infection; 2.Patients with a history of spinal surgery or those with other spinal diseases; 3.Patients with severe functional impairments of vital organs such as the heart, liver, brain, lungs and kidneys; 4.Pregnant or lactating women, or those with severe mental illnesses; 5.Patients with diabetes whose blood glucose control has not reached the target (fasting blood glucose >11.1mmol/L, glycated hemoglobin >8.0%), or those with diabetic complications; 6.Patients with uncontrolled hypertension (systolic blood pressure >=160mmHg, diastolic blood pressure >90mmHg), or those with hypotension (resting sitting blood pressure <90/50 mmHG).

Design outcomes

Primary

MeasureTime frame
operation blood loss;ESR;36-Item Short Form Health Survey, SF-36;CRP;Oswestry Disability Index score;Visual Analogue Scale score ;operation time;postoperative complications;

Secondary

MeasureTime frame
bone graft fusion;

Countries

China

Contacts

Public ContactDu Xing

The First Affiliated Hospital of Chongqing Medical University

878959354@qq.com+86 23 8901 1018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026